Non-targeted Metabolomics: A strategy for discovering potential clear cell Renal Cell Carcinoma biomarkers

ZABALEGUI NICOLAS; MALENA MANZI; MARÍA E. KNOTT; LYDIA I. PURICELLI; MARIA EUGENIA MONGE

Simposio; 3ro Simposio internacional: Frontiers in Bioscience; 2018

Renal Cell Carcinoma (RCC) is among the 10 most common cancers in both men and women, being clear cell renal cell carcinoma (ccRCC) the most common (75-80%) lethal subtype of kidney cancer. More than 50% of the patients exhibit locally advanced or metastatic RCC at the time of diagnosis and have a poor prognosis (5-year survival rate